• COVID-19
  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Fitbit, FibriCheck Expand Partnership to Deliver CE-Marked Heart Health Detection App in Europe

by Jasmine Pennic 03/03/2020 Leave a Comment

Fitbit, FibriCheck Expand Partnership to Deliver CE-Marked Heart Health Detection App in Europe

– Fitbit and FibriCheck have expanded their partnership to enable users in France, Germany, Italy, and Spain to monitor their heart rhythm for irregularities, such as Atrial Fibrillation (AFib), directly from their Fitbit smartwatch.

– The partnership was first announced in September 2019, when the FibriCheck app was made available to Fitbit smartwatch users in the UK, Ireland, the Netherlands, and Belgium. Since the app launched on Fitbit OS, more than 150,000 heart rhythm measurements have been taken.


Wearable leader Fitbit and FibriCheck, an innovative health screening and monitoring app, today announced they are expanding their partnership to enable users in France, Germany, Italy, and Spain to monitor their heart rhythm for irregularities, such as Atrial Fibrillation (AFib) directly from their Fitbit smartwatch. The FibriCheck software, which is CE marked, meets the performance standards for medical devices in the European Union (EU).

Impact of AFib in Europe

AFib, an irregular heart rhythm that is often difficult to detect or diagnose because of irregular occurrences, is a leading cause of stroke, the occurrence of which in Europe is predicted to increase to more than 800,000 by 2035[1]. The FibriCheck app for Fitbit smartwatches became available in September 2019 to Fitbit users in Belgium, Ireland, the Netherlands, and the UK. Since it launched on Fitbit OS, more than 150,000 heart rhythm measurements have been taken by users on their Fitbit smartwatch.

Check Your Heart Rhythm with Your Smartphone

The FibriCheck app runs on the Fitbit OS and uses Fitbit’s commercial-grade PPG (photoplethysmography) sensors – light-based technology that measures the rate of blood flow – to capture heart rhythm measurements from a user’s wrist. The measurement assessment can be viewed directly on the smartwatch screen and easily shared with medical professionals via a FibriCheck web interface to help diagnose conditions such as AFib.

The FibriCheck smartphone app has been available for users to measure their heart rhythm via the camera on their smartphones since 2016. A clinical trial was conducted to validate and support CE Marking of the FibriCheck application on Fitbit smartwatches. The trial compared FibriCheck on Fitbit smartwatches to gold-standard 12-lead ECG and state-of-the-art wearable single lead ECG technologies. The results indicated that the FibriCheck algorithm on Fitbit smartwatches was highly accurate in correctly detecting the presence of AFib when compared to ECG. As a result, this partnership between Fitbit and FibriCheck is expected to make trusted heart health monitoring accessible to more consumers in Europe.

Availability

FibriCheck will be available on Fitbit Versa™, Fitbit Versa Lite Edition™, Fitbit Versa 2™ and Fitbit Ionic™ devices and can be accessed through the Fitbit app gallery on smartphones. FibriCheck has a subscription model starting at €3.99 per month and a one-day free trial is available. A FibriCheck reading can be completed in 60 seconds. Instant, color-coded feedback is sent directly to the smartwatch screen; from green indicating that no irregularities have been detected, to red, which advises users to seek medical advice. A detailed report is also available via the FibriCheck smartphone app, which can be shared with medical professionals.

“For more than a decade, Fitbit has helped millions of people around the world take control of their health by providing them with a holistic picture of their health and wellness. Our partnership with FibriCheck expands on this vision by offering an accessible way for people to detect irregular heart rhythms using their Fitbit smartwatch, helping them to potentially identify and monitor heart conditions like Atrial Fibrillation,” said Nicola Maxwell, Director of Health Solutions & Services, EMEA for Fitbit.

RELATED:   How to Capitalize on Digital Health Momentum in 2021

Tagged With: Atrial Fibrillation, Clinical Trial, ecg, Fitbit, Heart, Medical Devices, model, sensors, Smartwatch

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

« Philips Launches Emergency Care Informatics Suite to Power Real-Time Feedback Between Emergency Responders & Doctors
XRHealth to Deliver VR Therapy to Coronavirus Patients in Quarantine in Israel »

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Recent Articles

  • Cerner Leadership Changes, Other Key Executives Hires

    ... more
  • QGenda acquires Shift Admin – M&A

    QGenda Acquires Automated Provider Scheduling Platform Shift Admin – M&A

    ... more
  • Telehealth After COVID-19: What's Next for the Healthcare Industry?

    Transitioning from Traditional to E-Fax: How Healthcare Communications are Transforming Post-COVID

    ... more
  • FCC COVID-19 Telehealth Program Providers

    FCC Unveils 14 Initial Projects Selected for $100M Connected Care Pilot Program

    ... more

Most Read

  • CVS Health Launches Senior Medical Alert System, Symphony CVS Health Launches Senior Medical Alert System, Symphony
  • 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021
  • 20 COVID-19 Predictions and Trends for 2021 - Executive Roundup 20 COVID-19 Predictions and Trends for 2021 – Executive Roundup
  • 20 COVID-19 Predictions and Trends for 2021 - Executive Roundup MEDITECH Launches Quick Vaccination Solution to Streamline COVID-19 Vaccination Process
  • ONC Issues First Health IT Standards Bulletin Discussing USCDI & SVAP ONC Issues First Health IT Standards Bulletin Discussing USCDI & SVAP
  • 16 COVID-19 Predictions and Trends for 2021 Executive Roundup 12-Available-COVID-19-Vaccine-Management-Solutions-to-Know-In-Depth-1 17 Recently Launched COVID-19 Vaccine Management Solutions to Know
  • COVID-19 Deferrals Lead to 3 Major Conditions Payers/Providers Must Address in 2021 COVID-19 Deferrals Lead to 3 Major Conditions Payers/Providers Must Address in 2021
  • FDA Approves COVID-19 Oral Fluid Test for Use Nationwide In-Depth: 32 FDA-Approved COVID-19 Testing Kits
  • 5G in Healthcare: 7 Advantages & Disadvantages for Providers to Know 5G in Healthcare: 7 Advantages & Disadvantages for Providers to Know
  • Heritage Group Healthcare PE Firm Heritage Group Launches $300M Health Tech Fund

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2020 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2021. HIT Consultant Media. All Rights Reserved. Privacy Policy |